CD8+ T Cell Cross-Reactivity Profiles and HIV-1 Immune Escape towards an HLA-B35-Restricted Immunodominant Nef Epitope

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Motozono, Chihiro ^a,b   Miles, John J ^a,c,d   Hasan, Zafrul ^b   Gatanaga, Hiroyuki ^b,e   Meribe, Stanley C ^b   Price, David A ^a   Oka, Shinichi ^b,e   Sewell, Andrew K ^a   Ueno, Takamasa ^b  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b KUMAMOTO UNIVERSITY   (Japan)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA B35 ANTIGEN; LEUCINE; NEF PROTEIN; PHENYLALANINE; UNCLASSIFIED DRUG; VALINE; VALYLPROLYLLEUCYLARGINYLPROLYLMETHIONYLTHREONYLTYROSINE; VIRUS RNA;

AMINO ACID SUBSTITUTION; ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CLONOGENESIS; CONTROLLED STUDY; CROSS REACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IN VIVO STUDY; MAJOR CLINICAL STUDY; PROTEIN BINDING; PROTEIN POLYMORPHISM; SEQUENCE ANALYSIS;

CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; GENE PRODUCTS, NEF; HIV-1; HLA-B35 ANTIGEN; HUMANS; IMMUNE EVASION; IMMUNODOMINANT EPITOPES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84879162101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066152     Document Type: Article

References (28)

1. Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, et al. (2009) HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS One 4: e6687.
2. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, et al. (2009) Adaptation of HIV-1 to human leukocyte antigen class I. Nature. 458: 641-645.
3. Mason D, (1998) A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 19: 395-404.
4. Sewell AK, (2012) Why must T cells be cross-reactive? Nat Rev Immunol 12: 669-677.
5. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, Skowera A, Miles JJ, et al. (2012) A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem 287: 1168-1177.
6. Dong T, Stewart-Jones G, Chen N, Easterbrook P, Xu X, et al. (2004) HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med 200: 1547-1557.
7. Kosmrlj A, Read EL, Qi Y, Allen TM, Altfeld M, et al. (2010) Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature 465: 350-354.
8. Iglesias MC, Almeida JR, Fastenackels S, van Bockel DJ, Hashimoto M, et al. (2011) Escape from highly effective public CD8+ T-cell clonotypes by HIV. Blood 118: 2138-2149.
9. Chen H, Ndhlovu ZM, Liu D, Porter LC, Fang JW, et al. (2012) TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat Immunol 13: 691-700.
10. Hoof I, Perez CL, Buggert M, Gustafsson RK, Nielsen M, et al. (2010) Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity. J Immunol 184: 5383-5391.
11. Ladell K, Hashimoto M, Iglesias MC, Wilmann PG, McLaren JE, et al. (2013) A Molecular Basis for the Control of Preimmune Escape Variants by HIV-Specific CD8(+) T Cells. Immunity 38: 425-436.
12. Motozono C, Yanaka S, Tsumoto K, Takiguchi M, Ueno T, (2009) Impact of intrinsic cooperative thermodynamics of peptide-MHC complexes on antiviral activity of HIV-specific CTL. J Immunol 182: 5528-5536.
13. Ueno T, Motozono C, Dohki S, Mwimanzi P, Rauch S, et al. (2008) CTL-mediated selective pressure influences dynamic evolution and pathogenic functions of HIV-1 Nef. J Immunol 180: 1107-1116.
14. Ueno T, Tomiyama H, Takiguchi M, (2002) Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules. J Immunol 169: 4961-4969.
15. De Rosa SC, Lu FX, Yu J, Perfetto SP, Falloon J, et al. (2004) Vaccination in humans generates broad T cell cytokine responses. J Immunol 173: 5372-5380.
16. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
17. Cole DK, Edwards ES, Wynn KK, Clement M, Miles JJ, et al. (2010) Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. J Immunol 185: 2600-2610.
18. Ekeruche-Makinde J, Miles JJ, van den Berg HA, Skowera A, Cole DK, et al. (2013) Peptide length determines the outcome of TCR/peptide-MHCI engagement. Blood 121: 1112-1123.
19. Douek DC, Betts MR, Brenchley JM, Hill BJ, Ambrozak DR, et al. (2002) A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol 168: 3099-3104.
20. Meyer-Olson D, Brady KW, Bartman MT, O'Sullivan KM, Simons BC, et al. (2006) Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire. Blood 107: 2373-2383.
21. Wooldridge L, Laugel B, Ekeruche J, Clement M, van den Berg HA, et al. (2010) CD8 controls T cell cross-reactivity. J Immunol 185: 4625-4632.
22. Ekeruche-Makinde J, Clement M, Cole DK, Edwards ES, Ladell K, et al. (2012) T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting. J Biol Chem 287: 37269-37281.
23. Bulek AM, Cole DK, Skowera A, Dolton G, Gras S, et al. (2012) Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes. Nat Immunol 13: 283-289.
24. Smith KJ, Reid SW, Stuart DI, McMichael AJ, Jones EY, et al. (1996) An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4: 203-213.
25. Saksela K, Cheng G, Baltimore D, (1995) Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J 14: 484-491.
26. Mwimanzi P, Hasan Z, Hassan R, Suzu S, Takiguchi M, et al. (2011) Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's functionality in primary macrophages. Retrovirology 8: 50.
27. Lee JK, Stewart-Jones G, Dong T, Harlos K, Di Gleria K, et al. (2004) T cell cross-reactivity and conformational changes during TCR engagement. J Exp Med 200: 1455-1466.
28. Yamada T, Kaji N, Odawara T, Chiba J, Iwamoto A, et al. (2003) Proline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen. J Virol 77: 1589-1594.